In return, Takeda will develop and commercialize the oral formulations of XEN401, a drug for the treatment of chronic and acute pain, in Japan and six other Asian countries. Xenon retains the rights to XEN401 for the rest of the world.Fasken Martineau DuMoulin LLP advised Takeda in this transaction with a team comprised of Roger Kuypers in Vancouver and Lucie Dufour in Montreal.Xenon's in-house counsel Karen Corraini was advised by a team from McCarthy Tétrault LLP comprised of John Pearson, Joyce Lee and Nazma Lee. … [Read more...] about Takeda Pharmaceutical in US$80M partnership with Xenon Pharmaceuticals
Fanali allo xenon
In Matrixx Initiatives, Inc. v. Siracusano, No. 09-1156, 2011 WL 977060 (U.S. Mar. 22, 2011), the United States Supreme Court (Sotomayor, J.) held unanimously that the materiality of an alleged false or misleading statement or omission for purposes of pleading a violation of Section 10(b) of the Securities Exchange Act of 1934, 15 U.S.C. § 78j(b), and Securities & Exchange Commission Rule 10b-5, 17 C.F.R. § 240.10b-5, is inherently fact-specific, depending upon whether a “reasonable investor” would have viewed the relevant information “as having significantly altered the total mix of information made available.” The Supreme Court declined to apply a “bright-line rule” that only “statistically significant” information regarding the safety of drug products is sufficiently material to support a Rule 10b-5 claim against a drug manufacturer based on a failure to disclose. This decision … [Read more...] about United States Supreme Court Reiterates Materiality Standard For Securities Fraud Claims Under Rule 10b-5
One method that has become appealing when attempting to establish anticipation as opposed to having to turn to obviousness is to utilize the idea of a secondary prior art reference being “incorporated by reference” within a primary prior art reference so as to establish the disclosure of each and every element of a challenged claim within a “single” prior art reference. That is, some suggest that because a secondary prior art reference is stated as being “incorporated by reference” into a primary prior art reference, the primary prior art reference should be considered as disclosing not only material expressly included therein, but also material disclosed in the secondary prior art reference. In one recent decision, this theory was tested with respect to establishing an earlier priority date to effectively preclude a reference as qualifying as prior art. In particular, in IPR2014-00664, IGB Automotive Ltd. and IG Bauerhin … [Read more...] about Can Priority Be Established Through Incorporation By Reference?
On October 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired UK-based Amdipharm Mercury Limited (AMCo) from Cinven Ltd, a leading European private equity firm, for approximately US$3.3 billion (the Acquisition) paid through a combination of cash and the issuance of 8.49 million common shares of Concordia. Concordia paid for the cash portion of the Acquisition with the proceeds from: (i) a public equity offering of common shares for gross proceeds of US$520 million led by Goldman, Sachs & Co. and RBC Capital Markets, as lead book running managers, and Credit Suisse Securities (USA) LLC and Jefferies LLC, as additional book running managers; (ii) a private placement of US$790 million of 9.5 per cent senior notes due 2022 by a syndicate of initial purchasers comprised of Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC, Jefferies LLC and RBC Capital Markets (the Initial … [Read more...] about Concordia Healthcare Corp. acquires Amdipharm Mercury Limited for US$3.3B
Under the arrangement, Canadian Solar and SkyPower will build and deploy solar energy solutions in Ontario and jointly develop solar projects internationally in select emerging markets. Under the completed transaction, Canadian Solar acquired a majority interest in 16 solar projects representing approximately 190-200MW DC from SkyPower. Each of these projects was awarded a 20-year power purchase contract by the Ontario Power Authority. Fifteen of these contracts were issued under Ontario's Feed-In-Tariff Program, and one was issued as part of Ontario's Renewable Energy Standard Offer Program. Canadian Solar and SkyPower have also agreed to form a 50:50 international joint venture called CSI SkyPower which will focus on developing solar power plants in Africa, the Middle East and South America. The transaction with Canadian Solar and the related corporate reorganization necessitated the restructuring of SkyPower's existing project financings with Norddeutsche Landesbank Girozentrale New … [Read more...] about Canadian Solar and Skypower Complete Solar Project Purchase and Launch International Joint Venture